Heart Rhythm O2 (Aug 2024)

Comparing outcomes after pulmonary vein isolation in patients with systolic and diastolic heart failure

  • Ahmad B. Allaw, MD,
  • Jeremy Treger, MD, PhD,
  • Jia Guo, MD,
  • Dipayon Roy, MD,
  • Amulya Gampa, MD,
  • Swati Rao, MD,
  • Stephanie A. Besser, MSAS,
  • Andrew D. Beaser, MD,
  • Zaid Aziz, MD,
  • Cevher Ozcan, MD,
  • Srinath Yeshwant, MD,
  • Gaurav A. Upadhyay, MD

Journal volume & issue
Vol. 5, no. 8
pp. 529 – 537

Abstract

Read online

Background: The benefit of pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) is well established; its efficacy in patients with heart failure preserved ejection fraction (HFpEF) is less clear. Objective: The objective of the study was to compare AF and heart failure (HF) rehospitalizations after PVI in patients with HFpEF vs HFrEF. Methods: The IBM MarketScan Database was used to identify patients undergoing PVI for AF. Patients were categorized by HF status: absence of HF, presence of HFrEF, or presence of HFpEF. Primary outcomes were HF and arrhythmia hospitalizations after PVI. Results: A total of 32,524 patients were analyzed: 27,900 with no HF (86%), 2948 with HFrEF (9%), and 1676 with HFpEF (5%). Compared with those with no HF, both patients with HFrEF and HFpEF were more likely to be hospitalized for HF (hazard ratio [HR] 7.27; P 1 year), patients with HFpEF were more likely to have HF (HR 1.30; P < .01) and arrhythmia (HR 1.19; P < .01) rehospitalizations. Conclusion: Reductions in HF and arrhythmia hospitalizations are observed early after PVI across all patients with HF, but patients with HFpEF demonstrate higher HF rehospitalization and arrhythmia recurrence in longer-term follow-up than do patients with HFrEF.

Keywords